INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 250
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Vida Health

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Employer/plan metabolic care, nutrition and behavior change with appropriate GLP-1 prescribing.

Audienceread

Our read: Employer/plan metabolic care, nutrition and behavior change with appropriate GLP-1 prescribing.

Pricing & termspartial

Benefit/contribution-specific; no universal direct fee. Medication separate.

Clinical relationshipspartial

Vida clinicians prescribe in Medical Weight Loss/designated-prescriber plans; PA-only members keep regular doctor. Legal practice name not established.

Pharmacy & fulfillmentpartial

Patient-selected retail/mail-order pharmacy. Vida explicitly does not send drugs.

Advertising snapshotsnapshot

Channel-specific public-library evidence below; counts are observations, never spend/performance.

Founding yearpartial

2014 (LinkedIn company listing)

Foundersverified

Stephanie Tilenius (2014 launch reporting).

Location & entity contextpartial

San Francisco, California (LinkedIn headquarters listing, not audited operational location)

Search visibility samplesnapshot

Public first-party program page found and read. Rankings, traffic, index totals and authority not measured.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.